NPM1 and acute myeloid leukemia: While its expression is associated with lower tumor burden, possibly mirroring the relatively homogeneous genomic makeup of NPM1-mutant AML, its overexpression in this traditionally favorable subgroup would indicate a higher propensity to immune suppression from AML cells, coupled with exhaustion of endogenous T cells.